Lisan Kuijper

Research output

Research output per year 2022 2022 2023 2024 2024

• 3 Article

Research output per year

Research output per year

Search results

• 2024

  mRNA-1273 vaccinated inflammatory bowel disease patients receiving TNF inhibitors develop broad and robust SARS-CoV-2-specific CD8+ T cell responses

  van den Dijssel, J., Duurland, M. C., Konijn, V. A. L., Kummer, L. Y. L., Hagen, R. R., Kuijper, L. H., Wieske, L., van Dam, K. P. J., Stalman, E. W., Steenhuis, M., Geerdes, D. M., Mok, J. Y., Kragten, A. H. M., Menage, C., Koets, L., Veldhuisen, B., Verstegen, N. J. M., van der Schoot, C. E., van Esch, W. J. E., D'Haens, G. R. AM., & 10 othersLöwenberg, M., Volkers, A. G., Rispens, T., Kuijpers, T. W., Eftimov, F., van Gisbergen, K. P. JM., van Ham, S. M., ten Brinke, A., van de Sandt, C. E. & T2B! immunity against SARS-CoV-2 study group, 1 Apr 2024, In: Journal of autoimmunity. 144, 103175.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
• 2023

  Distinct dynamics of antigen-specific induction and differentiation of different CD11c + Tbet + B cell subsets.

  T2B Consortium, Sept 2023, In: Journal of allergy and clinical immunology. 152, 3, p. 689-699.e6

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  6 Citations (Scopus)
• 2022

  Immune dynamics in SARS-CoV-2 experienced immunosuppressed rheumatoid arthritis or multiple sclerosis patients vaccinated with mRNA-1273

  T2B! immunity against SARS-CoV-2 study group & On behalf of the T2B immunity against SARS-CoV-2 study group, 15 Jul 2022, In: eLife. 11, 26 p., e77969.

  Research output: Contribution to journal › Article › Academic › peer-review

  Open Access
  11 Citations (Scopus)